BRCA1 and breast cancer: MiR-342 adjusts the BRCA1 expression by reducing the ID4 transcription factor involved in BC progression [131]; its reconstitution in TNBC cell lines led to caspase-dependent apoptosis but only in the presence of BRCA1 mutation.